KTN's online platform helps you to make the connections you need


The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.


The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

« go back

Funding opportunities for advanced therapy medicinal products

Blog from Sarah Goulding and Mark Bustard:

Greetings! As people come back from the ‘holidays’ KTN is checking in that you are exploring the Innovate UK funding calls currently available where advanced therapy medicinal products (ATMPs) are in scope -and that you can contact us at KTN for support.

These include BioMedical Catalyst (14 September deadline, up to £10 million to develop innovative ideas that will help solve healthcare challenges, our sector in scope particularly reference to 'tailored treatments that either change the underlying disease or offer potential cures’.

Also current is the £15 million Open Competition, though cross sector this includes any technology, engineering or industrial area, including Innovate UK’s 4 priority sectors for growth- e.g. , health and life sciences, total eligible project costs of £25,000 up to £1 million, deadline 7 September. 

Forthcoming for 2016 is the Health and Life Sciences call, planned is the cell therapy manufacturing call (both mentioned on page 17 of Innovate UK delivery plan).

KTN are also exploring how companies might use the Global Cooperation Feasibility Studies competition- where business can apply for a share of £1.2 million to carry out short, international feasibility studies - the competition brief mentions that they will fund SMEs to support the costs for their involvement in activities such as:

  • meetings with partners in the UK or other countries
  • travel and subsistence, including travelling abroad to meet partners, attend brokerage or exhibition events and gain a better understanding of market opportunities and user/customer needs
  • due diligence work on partners and markets
  • staff time for proof of market or concept work
  • sub-contracting services (limited to up to 10% of costs)

So this might be useful if exploring a collaboration partner through attending a key event in Q1 2017, or an EU proposal?

The recent Treasury announcement makes it clear that EU H2020 opportunities are very much open to UK business - such as the SME instrument  Cell technologies in medical applications and especially calls like the single stage SC1-PM-11-2016-2017 Clinical Research on regenerative medicine

It will also be interesting to see what opportunities might come out of the Innovative Medicines Initiative (IMI) Stakeholder Forum at end September where there is a dedicated advanced therapies discussion.

KTN continues to work alongside the National Contact Points (NCPs) for Health and the SME instrument, Innovate UK and Enterprise Europe Network (EEN) on how best to support businesses in applying for these calls. We also work closely with the Catapults key to this space.

Contact me or a colleague directly and we’ll help you to make an efficient decision on which call(s) might give you a non-diluting funding stream to drive forward your innovation, and business. We know that often this is a balance between current business strategy and precious time to develop proposals and collaborations.


Sarah Goulding and Mark Bustard

Sarah.goulding@ktn-uk.org ; mark.bustard@ktn-uk.org